Canada markets closed

ImmuCell Corporation (IUL.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
4.7000+0.0800 (+1.73%)
At close: 08:04AM CEST
Full screen
Previous Close4.6200
Open4.7000
Bid4.6800 x 300000
Ask4.8600 x 300000
Day's Range4.7000 - 4.7000
52 Week Range4.0600 - 5.4000
Volume60
Avg. Volume26
Market Cap37.137M
Beta (5Y Monthly)0.60
PE Ratio (TTM)N/A
EPS (TTM)-0.7000
Earnings DateMay 09, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024

    PORTLAND, Maine, April 09, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced preliminary, unaudited sales results for the first quarter of 2024, which ended March 31, 2024. Preliminary, Unaudited Total Sales Results: 20242023$ Increase % IncreaseDuring the T

  • Insider Monkey

    ImmuCell Corporation (NASDAQ:ICCC) Q4 2023 Earnings Call Transcript

    ImmuCell Corporation (NASDAQ:ICCC) Q4 2023 Earnings Call Transcript February 28, 2024 ImmuCell Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to the ImmuCell Corporation reports Fourth Quarter and Year Ended December 31, 2023 Unaudited Financial […]

  • GlobeNewswire

    ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023

    PORTLAND, Maine, Feb. 27, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced its unaudited financial results for the quarter and year ended December 31, 2023. Management’s Discussion: “Our unaudited, preliminary product sales for the fourth quarter of 2023 we